Logo

Logo

Mansukh Manadaviya

iNCOVACC is a testimony to innovative zeal of our scientists: Mansukh Mandaviya

Developed by Bharat Biotech International Limited (BBIL) in collaboration with Biotechnology Industry Research Assistance (BIRAC), a PSU under the Department of Biotechnology, Ministry of Science and Technology, iNCOVACC is the world's first intranasal Covid-19 vaccine to receive approval for the primary 2-dose schedule, and as a heterologous booster dose.